Live Breaking News & Updates on Hypertrophic cardiomyopathy center at oregon health

Stay informed with the latest breaking news from Hypertrophic cardiomyopathy center at oregon health on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hypertrophic cardiomyopathy center at oregon health and stay connected to the pulse of your community

Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS

Ahmad Masri, MD, MS, discusses a study from ACC.24 examining trends in incidence and outcomes of emergency department visits related to hypertrophic cardiomyopathy from 2006 to 2019.

Oregon , United-states , Ahmad-masri , Science-university , Science-university-knight-cardiovascular-institute , American-college-of-cardiology , Oregon-health , Hypertrophic-cardiomyopathy-center-at-oregon-health , Emergency-department-sample , Nationwide-emergency-department-sample , American-college , Annual-scientific-session

Ahmad Masri, MD, MS: 2024 Update on Development and Future of Cardiac Myosin Inhibitor Class

Ahmad Masri, MD, MS, provides an update on the the development of the cardiac myosin inhibitor class and offers perspective on what the future might hold for the class beyond cardiomyopathy.

Oregon , United-states , Canada , Canadian , Campbellp-cytokinetics , Ahmad-masri , Bristol-myers-squibb , Knight-cardiovascular-institute-at-oregon-health , Pfizer , Astrazeneca , York-heart-association , Drug-administration-approves-camzyos

Disparities for Time to HCM Diagnosis in Contemporary Care, with Ahmad Masri, MD, MS

Ahmad Masri, MD, MS, discusses a study he led examining disparities in time to diagnosis of hypertrophic cardiomyopathy using Medicare claims data.

United-states , Oregon , American , Ahmad-masri , American-heart-association-scientific-session , Science-university , Hypertrophic-cardiomyopathy-center-at-oregon-health , Hypertrophic-cardiomyopathy-center , Oregon-health , Hispanic-white ,

Expert Perspective: FDA CRDAC Vote on Patisiran for ATTR-CM, with Ahmad Masri, MD, MS

Ahmad Masri, MD, MS, provides his perspective on the APOLLO-B data and reacts to the FDA CRDAC 9 to 3 vote in favor of the benefit-risk profile for patisiran in ATTR-CM.

Oregon , United-states , Javed-butler , Ahmad-masri , Baylor-scott , Science-university-ahmad-masri , Science-university , Renal-drugs-advisory-committee , Drug-administration-cardiovascular , Advisory-committee , Division-of-cardiovascular-medicine , Oregon-health